aspartic acid has been researched along with Basal Ganglia Diseases in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (23.08) | 18.7374 |
| 1990's | 4 (30.77) | 18.2507 |
| 2000's | 3 (23.08) | 29.6817 |
| 2010's | 3 (23.08) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barker, GJ; Blain, CR; Guevara, CA; Leigh, PN; Lythgoe, DJ; Stahl, D | 1 |
| Balottin, U; Berardinelli, A; Brunstrom-Hernandez, JE; Collins, CD; Genni, AD; Mita, A; Novara, F; Orcesi, S; Schmidt, JL; Tonduti, D; Triulzi, F; Vanderver, A; Zuffardi, O | 1 |
| Fukazawa, Y; Mito, Y; Tajima, Y; Yanai, M | 1 |
| Fukuda, R; Fukui, T; Iwanami, A; Kasai, K; Kato, N; Kato, T; Yamasue, H | 1 |
| Furiya, Y; Hirano, M; Kichikawa, K; Kin, T; Takamure, M; Taoka, T; Ueno, S | 1 |
| Berry, RW; Bigio, E; Binder, LI; Cahill, ME; Glajch, KE; Guillozet-Bongaarts, AL; Libson, EG | 1 |
| Berl, S; Plaitakis, A | 1 |
| Akimoto, H; Fujimoto, T; Fukuzako, T; Nakano, T; Takano, T; Takeuchi, K; Yamada, K | 1 |
| Aotsuka, A; Hattori, T; Shinotoh, H | 1 |
| Furuya, S; Imahori, Y; Mizuno, T; Nakajima, K; Nakase, T; Naruse, S; Takanashi, Y | 1 |
| Berry, GT; Bilaniuk, LT; Gibson, J; Haselgrove, JC; Hunter, JV; Kaplan, BS; Kaplan, P; Lam, WW; Wang, ZJ; Zhao, H; Zimmermann, RA | 1 |
| Chang, LJ; Hornykiewicz, O; Kish, SJ; Mirchandani, L; Shannak, K | 1 |
| Meldrum, B | 1 |
2 review(s) available for aspartic acid and Basal Ganglia Diseases
| Article | Year |
|---|---|
[Magnetic resonance spectroscopy in Parkinson's disease and multiple system atrophy].
Topics: Aspartic Acid; Autonomic Nervous System Diseases; Basal Ganglia Diseases; Brain; Choline; Creatine; Diagnosis, Differential; Humans; Magnetic Resonance Spectroscopy; Parkinson Disease; Protons | 1997 |
Possible therapeutic applications of antagonists of excitatory amino acid neurotransmitters.
Topics: Alzheimer Disease; Animals; Aspartic Acid; Basal Ganglia Diseases; Brain; Brain Ischemia; Epilepsy; Excitatory Amino Acid Antagonists; Glutamates; Glutamic Acid; Humans; Huntington Disease; Mice; Movement Disorders; Nerve Degeneration; Neurotransmitter Agents; Parkinson Disease; Rats | 1985 |
11 other study(ies) available for aspartic acid and Basal Ganglia Diseases
| Article | Year |
|---|---|
Quantitative magnetic resonance spectroscopic imaging in Parkinson's disease, progressive supranuclear palsy and multiple system atrophy.
Topics: Aged; Aspartic Acid; Basal Ganglia Diseases; Biomarkers; Female; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Spectroscopy; Male; Middle Aged; Multiple System Atrophy; Neurons; Parkinson Disease; Predictive Value of Tests; Supranuclear Palsy, Progressive | 2010 |
MCT8 deficiency: extrapyramidal symptoms and delayed myelination as prominent features.
Topics: Aspartic Acid; Basal Ganglia Diseases; Brain; Child, Preschool; Choline; Chromosomes, Human, X; Codon, Nonsense; Developmental Disabilities; DNA Mutational Analysis; Follow-Up Studies; Hereditary Central Nervous System Demyelinating Diseases; Humans; Infant; Inositol; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Monocarboxylic Acid Transporters; Mutation, Missense; Nerve Fibers, Myelinated; Neurologic Examination; Sex Chromosome Aberrations; Symporters; Thyroid Function Tests | 2013 |
Unusual basal ganglia lesions in a diabetic uraemic patient proven to be demyelination: first pathological observation.
Topics: Aspartic Acid; Basal Ganglia; Basal Ganglia Diseases; Demyelinating Diseases; Diabetic Nephropathies; Diagnosis, Differential; Diffusion Magnetic Resonance Imaging; Follow-Up Studies; Humans; Japan; Macrophages; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Myelinolysis, Central Pontine; Neurologic Examination; Parkinson Disease; Putamen; Shock, Septic; Uremia | 2012 |
Drug-induced parkinsonism in relation to choline-containing compounds measured by 1H-MR spectroscopy in putamen of chronically medicated patients with schizophrenia.
Topics: Adult; Antipsychotic Agents; Aspartic Acid; Basal Ganglia Diseases; Choline; Chronic Disease; Creatine; Dominance, Cerebral; Energy Metabolism; Female; Glutamic Acid; Glutamine; Humans; Inositol; Magnetic Resonance Spectroscopy; Male; Middle Aged; Neurologic Examination; Parkinson Disease, Secondary; Phosphocreatine; Putamen; Reference Values; Schizophrenia; Schizophrenic Psychology | 2003 |
Proton MR spectroscopy of adult-onset dentatorubral-pallidoluysian atrophy.
Topics: Aged; Aspartic Acid; Atrophy; Basal Ganglia Diseases; Case-Control Studies; Choline; Creatine; Dentate Gyrus; Epilepsies, Myoclonic; Globus Pallidus; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Statistics, Nonparametric; Thalamus | 2005 |
Phosphorylation and cleavage of tau in non-AD tauopathies.
Topics: Aged; Aged, 80 and over; Aspartic Acid; Astrocytes; Basal Ganglia Diseases; Female; Humans; Immunohistochemistry; Male; Middle Aged; Phosphorylation; Pick Disease of the Brain; Serine; Supranuclear Palsy, Progressive; tau Proteins | 2007 |
Oral glutamate loading in disorders with spinocerebellar and extrapyramidal involvement: effect on plasma glutamate, aspartate and taurine.
Topics: Aspartic Acid; Atrophy; Basal Ganglia Diseases; Cerebellar Diseases; Cerebellum; Friedreich Ataxia; Glutamate Dehydrogenase; Glutamates; Glutamic Acid; Humans; Nerve Degeneration; Olivary Nucleus; Parkinson Disease; Pons; Shy-Drager Syndrome; Sodium Glutamate; Spinal Cord Diseases; Taurine | 1983 |
Proton magnetic resonance spectroscopy of basal ganglia in chronic schizophrenia.
Topics: Adult; Aspartic Acid; Basal Ganglia; Basal Ganglia Diseases; Brain Mapping; Choline; Chronic Disease; Creatine; Dominance, Cerebral; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Neurocognitive Disorders; Phosphocreatine; Protons; Psychiatric Status Rating Scales; Schizophrenia | 1996 |
[A lateralized reduction of NAA in a case of corticobasal degeneration (CBD): application of proton magnetic resonance spectroscopy (1H-MRS)].
Topics: Aged; Aspartic Acid; Basal Ganglia Diseases; Brain; Cerebral Cortex; Cerebrovascular Circulation; Female; Functional Laterality; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Neurodegenerative Diseases; Tomography, Emission-Computed | 1998 |
1H MR spectroscopy of the basal ganglia in childhood: a semiquantitative analysis.
Topics: Adolescent; Adult; Aspartic Acid; Basal Ganglia; Basal Ganglia Diseases; Brain Diseases, Metabolic; Child; Child, Preschool; Choline; Creatine; Energy Metabolism; Female; Humans; Infant; Inositol; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Reference Values | 1998 |
Progressive supranuclear palsy: relationship between extrapyramidal disturbances, dementia, and brain neurotransmitter markers.
Topics: Aged; Aspartic Acid; Basal Ganglia Diseases; Brain; Bulbar Palsy, Progressive; Choline O-Acetyltransferase; Dementia; Dopamine; Female; gamma-Aminobutyric Acid; Glutamates; Glutamic Acid; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Middle Aged; Neurons; Neurotransmitter Agents; Norepinephrine; Parkinson Disease, Secondary; Serotonin | 1985 |